BeiGene, Ltd. announced that in respect of the passing away of Mr. Glazer, an independent non-executive director of the Company and the chair of the Nominating and Corporate Governance Committee, and the non-compliance with Rule 3.27A of the Listing Rules. Unless otherwise defined, capitalized terms used in this announcement shall have the same meanings as the defined terms in the Announcement. The Company hereby announces that Ms. Shalini Sharp, an independent non-executive director of the Company, has been appointed as a member of the Nominating and Corporate Governance Committee and Mr. Anthony C. Hooper, an independent non-executive director of the Company, has been appointed as the Chair of the Nominating and Corporate Governance Committee, with effect from January 16, 2025 (U.S. Time).
The Nominating and Corporate Governance Committee consists of four members, namely Mr. Anthony C. Hooper, Mr. Michael Goller, Dr. Alessandro Riva and Ms. Shalini Sharp, with Mr. Anthony C. Hooper serving as the chair. Upon the appointment of Mr. Anthony C. Hooper as the chair of the Nominating and Corporate Governance Committee, the Company has re-complied with Rule 3.27A of the Listing Rules in respect of the requirement regarding establishing a nomination committee chaired by the chairman of the board or an independent non-executive director.
